BARCLAYS PLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$50
-18.0%
19,285
+11.2%
0.00%
Q2 2023$61
+13.0%
17,340
+0.2%
0.00%
Q1 2023$54
-26.0%
17,2980.0%0.00%
Q4 2022$73
-99.9%
17,298
-68.0%
0.00%
Q3 2022$129,000
-20.9%
54,110
-5.2%
0.00%
Q2 2022$163,000
-9.9%
57,066
-8.4%
0.00%
Q1 2022$181,000
-65.6%
62,308
-64.1%
0.00%
Q4 2021$526,000
+17.9%
173,374
+172.4%
0.00%
Q3 2021$446,000
-3.7%
63,643
+25.9%
0.00%
Q2 2021$463,000
-25.9%
50,531
-21.5%
0.00%
Q1 2021$625,000
-22.8%
64,349
-18.5%
0.00%
Q4 2020$810,000
-21.5%
78,932
-22.8%
0.00%
-100.0%
Q3 2020$1,032,000
-12.5%
102,215
-9.7%
0.00%0.0%
Q2 2020$1,180,000
+36.6%
113,161
+10.5%
0.00%0.0%
Q1 2020$864,000
+8.0%
102,431
+12.0%
0.00%
Q4 2019$800,000
-22.5%
91,432
-4.7%
0.00%
-100.0%
Q3 2019$1,032,000
+35.3%
95,975
+59.9%
0.00%
Q2 2019$763,000
-39.4%
60,030
+84.9%
0.00%
-100.0%
Q1 2019$1,259,000
+62.7%
32,463
-14.7%
0.00%
Q4 2018$774,000
-87.1%
38,059
-70.9%
0.00%
-100.0%
Q3 2018$6,003,000
+43.7%
130,911
+85.4%
0.00%0.0%
Q2 2018$4,177,000
+242.9%
70,624
+294.7%
0.00%
+300.0%
Q1 2018$1,218,000
-91.5%
17,891
-87.7%
0.00%
-91.7%
Q4 2017$14,383,000
-44.8%
145,505
-33.1%
0.01%
-55.6%
Q3 2017$26,065,000
+110.8%
217,649
+53.9%
0.03%
+92.9%
Q2 2017$12,364,000
+388.3%
141,462
+107.8%
0.01%
+366.7%
Q1 2017$2,532,000
+776.1%
68,062
+623.4%
0.00%
Q4 2016$289,000
+1056.0%
9,409
+2395.8%
0.00%
Q3 2016$25,000
-78.3%
377
-90.5%
0.00%
Q1 2016$115,000
+105.4%
3,961
+453.2%
0.00%
Q4 2015$56,000
-97.1%
716
-97.2%
0.00%
-100.0%
Q3 2015$1,940,000
-83.5%
25,855
-74.5%
0.00%
-84.6%
Q2 2015$11,740,000
+195.4%
101,208
+501.1%
0.01%
+225.0%
Q1 2015$3,974,000
-31.6%
16,838
-45.2%
0.00%
-33.3%
Q4 2014$5,811,000
-77.2%
30,742
-71.3%
0.01%
-75.0%
Q3 2014$25,481,000
+65.8%
107,065
-54.0%
0.02%
+50.0%
Q2 2014$15,367,000
+2286.2%
232,827
+3660.7%
0.02%
+1500.0%
Q1 2014$644,000
-13.0%
6,191
-13.8%
0.00%0.0%
Q4 2013$740,000
+103.3%
7,181
+4.6%
0.00%
Q3 2013$364,000
+600.0%
6,865
+491.3%
0.00%
Q2 2013$52,0001,1610.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders